Highland Capital Management LP grew its position in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) by 72.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 55,100 shares of the company’s stock after buying an additional 23,100 shares during the period. Highland Capital Management LP owned 0.06% of Acadia Healthcare worth $2,254,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Alpine Woods Capital Investors LLC bought a new stake in shares of Acadia Healthcare during the 2nd quarter valued at $153,000. New Jersey Better Educational Savings Trust bought a new stake in shares of Acadia Healthcare during the 2nd quarter valued at $205,000. Cubist Systematic Strategies LLC bought a new stake in shares of Acadia Healthcare during the 1st quarter valued at $255,000. Bbva Compass Bancshares Inc. bought a new stake in shares of Acadia Healthcare during the 2nd quarter valued at $259,000. Finally, BNP Paribas Arbitrage SA raised its stake in shares of Acadia Healthcare by 118.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 8,425 shares of the company’s stock valued at $345,000 after purchasing an additional 4,566 shares during the period.

A number of research firms recently issued reports on ACHC. ValuEngine lowered Acadia Healthcare from a “sell” rating to a “strong sell” rating in a research note on Thursday, September 6th. BidaskClub upgraded Acadia Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, September 6th. Zacks Investment Research upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a research note on Tuesday, July 24th. Credit Suisse Group upped their target price on Acadia Healthcare from $40.00 to $44.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 31st. Finally, Jefferies Financial Group upped their target price on Acadia Healthcare from $44.00 to $47.00 and gave the stock a “buy” rating in a research note on Tuesday, July 31st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have assigned a buy rating to the company’s stock. Acadia Healthcare presently has an average rating of “Buy” and a consensus price target of $44.36.

In related news, Director Reeve B. Waud sold 8,135 shares of the stock in a transaction dated Thursday, July 26th. The stock was sold at an average price of $45.00, for a total transaction of $366,075.00. Following the completion of the sale, the director now directly owns 14,213 shares in the company, valued at approximately $639,585. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 2.50% of the company’s stock.

Shares of ACHC stock opened at $37.30 on Wednesday. The stock has a market cap of $3.43 billion, a P/E ratio of 16.22, a P/E/G ratio of 1.39 and a beta of 0.61. Acadia Healthcare Company Inc has a 1-year low of $26.92 and a 1-year high of $49.05. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.24 and a quick ratio of 1.24.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Monday, July 30th. The company reported $0.70 earnings per share for the quarter, meeting the consensus estimate of $0.70. The company had revenue of $765.70 million during the quarter, compared to analysts’ expectations of $767.93 million. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. Acadia Healthcare’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.66 EPS. equities research analysts expect that Acadia Healthcare Company Inc will post 2.52 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Recommended Story: Marijuana Stocks Investing Considerations

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.